FIBROCELL SCIENCE INC's ticker is FCSC and the CUSIP is 315721209. A total of 32 filers reported holding FIBROCELL SCIENCE INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $38,000 | -75.8% | 15,300 | -42.7% | 0.05% | -80.8% |
| Q4 2015 | $157,000 | +31.9% | 26,710 | -13.9% | 0.24% | +12.9% |
| Q3 2015 | $119,000 | -30.8% | 31,010 | -5.5% | 0.22% | -27.2% |
| Q2 2015 | $172,000 | +8.9% | 32,810 | -6.6% | 0.30% | +4.2% |
| Q1 2015 | $158,000 | +507.7% | 35,110 | +247.6% | 0.29% | +793.8% |
| Q4 2014 | $26,000 | – | 10,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 16,620,414 | $11,967,000 | 0.56% |
| Healthcare Value Capital, LLC | 147,769 | $106,000 | 0.17% |
| MSD Partners, L.P. | 2,078,877 | $1,497,000 | 0.12% |
| QVT Financial LP | 465,672 | $335,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 50,000 | $36,000 | 0.01% |
| STALEY CAPITAL ADVISERS INC | 98,500 | $71,000 | 0.01% |
| STONERIDGE INVESTMENT PARTNERS LLC | 43,087 | $31,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 145,021 | $104,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 250,803 | $181,000 | 0.00% |
| Mount Lucas Management LP | 25,000 | $18,000 | 0.00% |